Literature DB >> 34034829

A rare case of Polyarteritis Nodosa associated with autoimmune hepatitis: a case report.

Freda Kennedy1, Rachel Kapelow1,2, Bilge D Kalyon3, Nitzan C Roth4, Arvind Rishi5, Maria-Louise Barilla-LaBarca6,7.   

Abstract

BACKGROUND: Polyarteritis nodosa is a type of vasculitis affecting medium- and small-sized arteries that has been associated with hepatitis B but does not have an established relationship with autoimmune hepatitis. Here we report the case of an adult patient with autoimmune hepatitis who, shortly after diagnosis, developed life-threatening polyarteritis nodosa. CASE
PRESENTATION: A 45-year-old woman was diagnosed with autoimmune hepatitis after initially presenting with a two-month history of fatigue, nausea, and anorexia and a three-week history of scleral icterus. Her liver biopsy showed mild portal fibrosis and her liver chemistries improved with prednisone and azathioprine. Three months later, she presented to the emergency department with fever, bilateral ankle pain, rash, oral ulcers, and poor vision. Physical examination was notable for erythema nodosum, anterior uveitis, retinal vasculitis, and frosted branch angiitis (frosted branch angiitis (a widespread florid translucent perivascular exudate). She subsequently developed repeated episodes of ischemic acute bowel necrosis that required multiple surgeries and extensive small bowel resections. Surgical pathology of the small bowel resection revealed ischemic necrosis, medium and small vessel vasculitis with microvascular thrombi consistent with polyarteritis nodosa. Azathioprine was discontinued and she was treated with pulse steroids followed by a prednisone taper, cyclophosphamide, and intravenous immune globulin with overall improvement in her symptomatology. Since her hospitalization, she has been maintained on low-dose prednisone and mycophenolate mofetil.
CONCLUSIONS: In patients with recent diagnosis of autoimmune hepatitis, there should be a modest suspicion for concomitant polyarteritis nodosa if symptoms and signs of multisystem vasculitis develop.

Entities:  

Keywords:  Autoimmune hepatitis; Azathioprine; Cyclophosphamide; Polyarteritis nodosa

Year:  2021        PMID: 34034829     DOI: 10.1186/s41927-021-00188-1

Source DB:  PubMed          Journal:  BMC Rheumatol        ISSN: 2520-1026


  10 in total

Review 1.  Polyarteritis nodosa: A contemporary overview.

Authors:  Armando De Virgilio; Antonio Greco; Giuseppe Magliulo; Andrea Gallo; Giovanni Ruoppolo; Michela Conte; Salvatore Martellucci; Marco de Vincentiis
Journal:  Autoimmun Rev       Date:  2016-02-13       Impact factor: 9.754

2.  A case of cutaneous polyarteritis nodosa in autoimmune hepatitis.

Authors:  Woo Jin Lee; Chae Hwa Kim; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Kee Chan Moon; Jai Kyoung Koh
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

3.  Polyarteritis nodosa: lessons from 25 years of experience.

Authors:  Hafize Emine Sönmez; Berkan Armağan; Gizem Ayan; Kenan Barut; Ezgi Deniz Batu; Abdulsamet Erden; Serdal Uğurlu; Yelda Bilginer; Özgur Kasapçopur; Ömer Karadağ; Sule Apras Bilgen; Huri Özdoğan; Seza Ozen
Journal:  Clin Exp Rheumatol       Date:  2018-10-30       Impact factor: 4.473

4.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Authors:  Christian Pagnoux; Raphaèle Seror; Corneliu Henegar; Alfred Mahr; Pascal Cohen; Véronique Le Guern; Boris Bienvenu; Luc Mouthon; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2010-02

5.  Polyarteritis nodosa in a patient with type 1 autoimmune hepatitis.

Authors:  Olga Giouleme; Alexander Mpoumponaris; Spiridon Aslanidis; Panagiotis Anagnostis; Panagiotis Giamalis; Nikolaos Nikolaidis; Themistoklis Vasiliadis; Nikolaos Evgenidis
Journal:  South Med J       Date:  2011-01       Impact factor: 0.954

6.  Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.

Authors:  Sezgin Sahin; Amra Adrovic; Kenan Barut; Serdal Ugurlu; Eda Tahir Turanli; Huri Ozdogan; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2017-05-17       Impact factor: 2.631

Review 7.  Autoimmune hepatitis: classification, heterogeneity, and treatment.

Authors:  E L Krawitt
Journal:  Am J Med       Date:  1994-01-17       Impact factor: 4.965

Review 8.  Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.

Authors:  Hasan Hashem; Susan J Kelly; Nancy J Ganson; Michael S Hershfield
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.592

9.  Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.

Authors:  Y A Akova; N S Jabbur; C S Foster
Journal:  Ophthalmology       Date:  1993-12       Impact factor: 12.079

Review 10.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

  10 in total
  1 in total

Review 1.  Autoimmune liver diseases in systemic rheumatic diseases.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.